Cite
HARVARD Citation
Martin, T. et al. (2022). Health-related quality of life in patients given ciltacabtagene autoleucel for relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b–2, open-label study. Lancet. 9 (12), pp. e897-e905. [Online].